Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 5.58 is 22% below its 5-year average of 7.20, near the low end of its 5-year range (0.36–18.37).
As of the fiscal period ended Tuesday, June 30, 2026. 37.67% above its 12-month average of 4.05.
Reported quarterly quick ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 5.58.
QUICK RATIO (ACID-TEST)
5.58
QUICK RATIO (ACID-TEST) AVG TTM
4.05
QUICK RATIO (ACID-TEST) AVG 3Y
4.77
QUICK RATIO (ACID-TEST) AVG 5Y
7.20
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+37.67%
CURRENT VS 3Y AVG
+16.96%
CURRENT VS 5Y AVG
-22.50%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.19
median of 771 covered companies
CURRENT VS SECTOR MEDIAN
+74.82%
vs the sector median at left
CalciMedica, Inc.
Market Cap
$4.82M
Quick Ratio (Acid-Test)
5.58
TTM Avg
4.05
3Y Avg
4.77
5Y Avg
7.20
Market Cap
$4.64M
Quick Ratio (Acid-Test)
7.22
TTM Avg
2.13
3Y Avg
2.10
5Y Avg
5.04
Market Cap
$4.53M
Quick Ratio (Acid-Test)
1.35
TTM Avg
3.30
3Y Avg
6.18
5Y Avg
6.77
Market Cap
$4.52M
Quick Ratio (Acid-Test)
2.73
TTM Avg
3.29
3Y Avg
4.75
5Y Avg
4.47
Market Cap
$4.86M
Quick Ratio (Acid-Test)
10.60
TTM Avg
4.75
3Y Avg
13.37
5Y Avg
23.75
Market Cap
$4.38M
Quick Ratio (Acid-Test)
40.30
TTM Avg
26.48
3Y Avg
43.98
5Y Avg
50.08
Market Cap
$4.21M
Quick Ratio (Acid-Test)
1.95
TTM Avg
2.83
3Y Avg
3.75
5Y Avg
3.40
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| CalciMedica, Inc. (CALC) | $4.82M | 5.58 | 4.05 | 4.77 | 7.20 |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.64M | 7.22 | 2.13 | 2.10 | 5.04 |
| CollPlant Biotechnologies Ltd. (CLGN)vs › | $4.53M | 1.35 | 3.30 | 6.18 | 6.77 |
| Dermata Therapeutics, Inc. (DRMA)vs › | $4.52M | 2.73 | 3.29 | 4.75 | 4.47 |
| Lexaria Bioscience Corp. (LEXX)vs › | $4.86M | 10.60 | 4.75 | 13.37 | 23.75 |
| PharmaCyte Biotech, Inc. (PMCB)vs › | $4.38M | 40.30 | 26.48 | 43.98 | 50.08 |
| 20/20 Biolabs Inc. (AIDX)vs › | $4.21M | 1.95 | 2.83 | 3.75 | 3.40 |
| GRI Bio, Inc. (GRI)vs › | $4.15M | 10.30 | 3.34 | 1.98 | 1.38 |
| Imunon, Inc. (IMNN)vs › | $5.04M | 1.82 | 1.99 | 2.53 | 3.43 |
| Processa Pharmaceuticals, Inc. (PCSA)vs › | $4.11M | 0.87 | 1.88 | 4.97 | 8.67 |
Quick Ratio
5.58
Excludes inventory
Current Ratio
5.58
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-06-30 | 5.58 |
| 2026-03-31 | 1.61 |
| 2025-12-31 | 3.58 |
| 2025-09-30 | 4.04 |
| 2025-06-30 | 5.45 |
| 2025-03-31 | 5.66 |
| 2024-12-31 | 5.34 |
| 2024-09-30 | 4.15 |
| 2024-06-30 | 5.22 |
| 2024-03-31 | 6.21 |
| 2023-12-31 | 2.88 |
| 2023-09-30 | 4.14 |
| 2023-06-30 | 4.98 |
| 2023-03-31 | 2.73 |
| 2022-12-31 | 0.36 |
| 2022-09-30 | 11.98 |
| 2022-06-30 | 11.95 |
| 2022-03-31 | 13.77 |
| 2021-12-31 | 16.54 |
| 2021-09-30 | 16.59 |
| 2021-06-30 | 18.37 |
| 2021-03-31 | 14.15 |
| 2020-12-31 | 14.18 |
| 2020-09-30 | 12.29 |
| 2020-06-30 | 2.45 |
| 2020-03-31 | 0.00 |
| 2019-12-31 | 2.96 |
| 2019-09-30 | 0.00 |
